|
2019 Conference Publication An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neckFoote, Matthew, Smithers, Mark, Hong, Angela, Fogarty, Gerald, Scolyer, Richard, Paton, Elizabeth, Barker, Christopher, Chua, Margaret, Shannon, Kerwin, Burmeister, Bryan, Nobes, Jenny and Williams, Narelle (2019). An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY. |
|
2019 Conference Publication ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neckFoote, M., Smithers, M., Hong, A., Fogarty, G., Scolyer, R., Paton, E., Barker, C., Chua, M., Shannon, K., Burmeister, B. and Nobes, J. (2019). ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY. |
|
2019 Conference Publication Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-IRand, J. G., Kirchoff, D., Deutsch, G., Stern, S., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Sondak, V., Coventry, B., Kashani-Sabet, M., Smithers, M., Paul, E., Kraybill, W., Elashoff, R., Lee, D. and Faries, M. B. (2019). Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I. 72nd Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), San Diego Ca, Mar 27-30, 2019. NEW YORK: SPRINGER. |
|
2019 Conference Publication Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibitionAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan, Shirai, Keisuki, Essner, Richard, Smithers, Bernard M., Atkinson, Victoria, Sarson, David and Wachter, Eric A. (2019). Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibition. LONDON: BMC. |
|
2019 Conference Publication Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanomaTie, Emilia Nan, Lai-Kwon, Julia Elizabeth, Na, Lumine, Rtshiladze, Michael Alexander, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V., McArthur, Grant A., Sandhu, Shahneen Kaur, Saw, Robyn, Walpole, Euan Thomas, Menzies, Alexander M., Smithers, B. Mark and Gyorki, David E. (2019). Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 31 May - 4 June 2019. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2019 Conference Publication Melanoma patient survival: Prognostic value of pSTAT5 as a biomarkerChong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapyTrada, Y., Law, P. W., Bernard, A., Foote, M. C., Barbour, A., Lambie, D., Smithers, M., Burmeister, B. and Pinkham, M. B. (2019). FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy. 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Chicago, Illinois, 15-18 September 2019 . Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.ijrobp.2019.06.2489 |
|
2019 Conference Publication Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysisMiura, J. T., Kroon, H. M., Beasley, G., Farrow, N. E., Mosca, P. J., Lowe, M., Farley, C., Kim, Y., Naqvi, S., Potdar, A., Daou, H., Sun, J., Mullen, D., Farma, J., Henderson, M., Serpell, J., Delman, K. A., Smithers, M., Coventry, B., Tyler, D. S., Thompson, J. and Zager, J. (2019). Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis. 72nd Annual Cancer Symposium of the Society of Surgical Oncology (SSO), San Diego, California, 27-30 March 2019 . New York, NY, United States: Springer. |
|
2019 Conference Publication SOX18 activation in primary melanoma tumoursChong, S., Rowe, C., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2019). SOX18 activation in primary melanoma tumours. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanomaAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan S., Shirai, Keisuke, Essner, Richard, Smithers, Bernard Mark, Atkinson, Victoria and Wachter, Eric Andrew (2019). Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il, United States, May 31-June 4, 2019. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2019.37.15_suppl.9559 |
|
2019 Conference Publication Clinicopathological factors associated with death from thin (<= 1 mm) melanomaClaeson, M., Baade, P., Brown, S., Soyer, P., Smithers, M., Green, A., Whiteman, D. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin ( |
|
2019 Conference Publication IRF4 rs12203592*T/T genotype is associated with nodular melanomaRayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H. Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. ASDR Annual Scientific Meeting 2019, Melbourne, VIC, Australia, 16-17 May 2019. |
|
2018 Conference Publication Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinomaBarbour, A. P., Walpole, E. T., Mai, G. T., Barnes, L., Watson, D. I., Ackland, S. P., Wills, V., Martin, J., Burge, M., Karapetis, C. S., Shannon, J., Nott, L. M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J. R., Simes, J. and Smithers, M. (2018). Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma. 43rd ESMO Congress (ESMO), Munich Germany, Oct 19-23, 2018. OXFORD: OXFORD UNIV PRESS. |
|
2018 Conference Publication Overview of melanoma genetics for dermatologists and results of a genetic analysis of multiple primary melanoma patientsMoMeniman, E., Sturm, R., Duffy, D., Jagirdar, K., Lee, K., Finnane, A., De'Ambrosis, B., Smithers, M. and Soyer, H. P. (2018). Overview of melanoma genetics for dermatologists and results of a genetic analysis of multiple primary melanoma patients. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, Australia, 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/ajd.14_12815 |
|
2018 Conference Publication Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapyBarbour, A. P., Brosda, S., Wijnhoven, B., van Hootgem, S., Lanschot, J. J. B., Barbour, S., Lagarde, S., Krause, L., Pryor, D., Thomas, J., Walpole, E. T., van der Gaast, A. and Smithers, M. (2018). Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. 43rd ESMO Congress (ESMO), Munich, Germany, 19-23 October 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdy282.015 |
|
2018 Conference Publication Oncolytic immunotherapy with PV-10Agarwala, Sanjiv, Smithers, B. Mark, Haushild, Axel, Ascierto, Paolo A. and Watcher, Eric (2018). Oncolytic immunotherapy with PV-10. Immunotherapy Bridge 2017, Naples, Italy, 29 November - 2 December 2017. London, United Kingdom: BioMed Central. doi: 10.1186/s12967-017-1352-z |
|
2018 Conference Publication Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanomaChong, S., Green, A., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2018). Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.17_12815 |
|
2017 Conference Publication Outcomes of complex cancer surgery in QueenslandSmithers, Mark, Theile, David E., Philpot, Shoni, Guan, Tracey and Dunn, Nathan (2017). Outcomes of complex cancer surgery in Queensland. COSA's 44th Annual Scientific Meeting, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12798 |
|
2017 Conference Publication Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgeryBarbour, Andrew P., McCormack, Orla M. , Baker, Peter J., Hirst, Jodi, Krause, Lutz, Brosda, Sandra, Thomas, Janine M., Blazeby, Jane M., Thomson, Iain G., Gotley, David C. and Smithers, Bernard M. (2017). Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgery. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/SLA.0000000000001899 |
|
2017 Conference Publication Outcome predictors in median arcuate ligament syndromeHo, Kelvin Kam Fai, Walker, Philip, Smithers, B. Mark, Foster, Wallace, Nathanson, Leslie, O'Rourke, Nicholas, Shaw, Ian and McGahan, Timothy (2017). Outcome predictors in median arcuate ligament syndrome. Royal Australasian College of Surgeons Annual Scientific Congress and the Australia and New Zealand Society for Vascular Surgery Annual Scientific Meeting, Canberra, Australia, 11-13 October 2014. Philadelphia, PA United States: Mosby. doi: 10.1016/j.jvs.2016.11.040 |
